Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX
Galson Steven K received 15,294 Biocryst Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Galson Steven K (Director) received 15,294 Biocryst Pharmaceuticals, Inc. shares as an award, leaving 27,794 shares. Filed Jun 15, 2026 (Form 4).
- Awarded
- 15,294 shares
- Holding after
- 27,794 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 15,294 | 27,794 | Direct |